Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth-powered prescription skincare platform connecting patients with licensed dermatology providers online; pioneering custom compounded serums with tretinoin, niacinamide, and clindamycin shipped directly; projected revenue approaching $100M annually.
Curology is a San Francisco-based telehealth skincare company founded in 2014 by Dr. David Lortscher. The platform connects patients with licensed dermatology providers who review photos and skin concerns online, then prescribe custom compounded serums containing pharmaceutical actives such as tretinoin, niacinamide, and clindamycin. Products are shipped directly to subscribers as part of a monthly plan.\n\nCurology has raised approximately $40 million in venture funding and projects revenues approaching $100 million annually. The company has expanded its service beyond acne treatment to cover anti-aging, melasma, and rosacea. It launched a sister brand, Agency, specifically targeting men's skincare concerns. The combination of telehealth prescription authority with DTC manufacturing and delivery positions Curology at the intersection of digital health and beauty — a unique regulatory moat that over-the-counter brands cannot replicate.\n\nThe brand has attracted a loyal subscriber base among millennial and Gen Z consumers who prefer personalized, clinician-backed skincare over generic pharmacy products. By eliminating the in-person dermatology visit, Curology democratizes access to prescription-strength ingredients at a fraction of traditional office costs.
Apple Watch, $18B+ revenue 2024, 22% global smartwatch market share, 34% US wearables market, 100M+ active users, Series 10 (2024): sleep apnea detection, blood oxygen, ECG, fall detection, watchOS 11, fitness tracking leader
Apple Watch was introduced in 2015 as Apple's entry into personal computing worn on the wrist, designed to extend the iPhone experience to the body and provide health and fitness intelligence unavailable from any other consumer device. Apple's mission for the product evolved rapidly from notification delivery to health monitoring, driven by the recognition that continuous, passive measurement of physiological signals could provide clinically meaningful insights at population scale. Its core technology integrates custom Apple silicon, optical heart rate sensors, an electrical heart sensor for ECG, a blood oxygen sensor, and accelerometers within an ultra-compact, water-resistant enclosure running watchOS.\n\nApple Watch Series 10 (2024) introduced sleep apnea detection — a first for any consumer wearable — joining an existing health feature set that includes ECG, irregular heart rhythm notifications, blood oxygen monitoring, crash detection, and fall detection. The Apple Watch platform connects tightly with the Health app and iPhone ecosystem, with third-party app integrations across fitness, medication tracking, mental health, and chronic disease management. Apple Watch serves a broad customer base from fitness-focused consumers to patients with prescribed monitoring needs, supported by FDA clearances on its core health features.\n\nApple Watch generated an estimated $18 billion or more in revenue in 2024, capturing approximately 22% of global smartwatch market share and 34% of the US wearables market, with more than 100 million active users globally. It competes with Samsung Galaxy Watch and Garmin but has no peer in terms of health feature depth, ecosystem integration, and installed base. As regulatory bodies and health systems increasingly recognize wearable-derived data as clinically actionable, Apple Watch's combination of consumer scale and health credibility positions it as the de facto platform for digital health at the consumer level.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.